March 12, 2019
UCB Japan and its partner Daiichi Sankyo have launched a dry syrup version of their anti-epilepsy drug Vimpat (lacosamide) on March 11 for the treatment of partial onset seizures in epilepsy patients with or without secondary generalization, the two companies...read more